The impact of heparin-coated cardiopulmonary bypass circuits on pulmonary function and the release of inflammatory mediators.

作者: R. de Vroege , W. van Oeveren , J. van Klarenbosch , W. Stooker , M. A. J. M. Huybregts

DOI: 10.1213/01.ANE.0000114551.64123.79

关键词: Cardiopulmonary bypassArteryHeparinLungInternal medicineAnesthesiaPulmonary function testingMedicineAprotininCardiologyFraction of inspired oxygenPulmonary shunt

摘要: Reduction of the inflammatory reaction with use heparin coating has been found during and after cardiopulmonary bypass (CPB). The question remains whether this reduced also decreases magnitude CPB-induced pulmonary dysfunction. We therefore evaluated effects a heparin-coated circuit versus similar uncoated on indices as well markers complement activation (C3b/c), elastase-alpha(1)-antitrypsin complex, secretory phospholipase A, (sPLA,) CPB. Fifty-one patients were randomly assigned into two groups undergoing coronary artery grafting either (Group 1) or an 2) circuit. During CPB, continuous positive airway pressure 5 cm H2O fraction inspired oxygen (Fio(2)) 0.21 maintained. Differences in favor coated shunt (P <0.05), vascular resistance index Pao(2)/Fio(2) ratio <0.05) CPB intensive care unit. group demonstrated lower levels sPLA(2). After C3b/c elastase-alantitrypsin complex significantly less <0.001). was associated response, decreased fraction, increased Pao2/Fio2 ratio, suggesting that may have beneficial function. correlation sPLA2, leukocyte activation, postoperative count suggests capillary endothelial cells.

参考文章(32)
D Dors, L G Thijs, J H Nuijens, A J Kamp, J J Abbink, C E Hack, A J Eerenberg, R W Colman, Y T Wachtfogel, R J Strack van Schijndel, Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis. Journal of Laboratory and Clinical Medicine. ,vol. 119, pp. 159- 168 ,(1992)
N.J.G. Jansen, W. van Oeveren, L.v.d. Broek, H.M. Oudemans-van Straaten, C.P. Stoutenbeek, M. Chang Njoek Joen, K.J. Roozendaal, L. Eysman, C.R.H. Wildevuur, Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass The Journal of Thoracic and Cardiovascular Surgery. ,vol. 102, pp. 515- 525 ,(1991) , 10.1016/S0022-5223(20)31421-5
A.C. Cave, A. Manché, N.W. Derias, D.J. Hearse, Thromboxane A2 mediates pulmonary hypertension after cardiopulmonary bypass in the rabbit. The Journal of Thoracic and Cardiovascular Surgery. ,vol. 106, pp. 959- 967 ,(1993) , 10.1016/S0022-5223(19)33966-2
E.A. Dennis, Diversity of group types, regulation, and function of phospholipase A2. Journal of Biological Chemistry. ,vol. 269, pp. 13057- 13060 ,(1994) , 10.1016/S0021-9258(17)36794-7
S. Buysmann, M. C. Brouwer, I. J. M. Ten Berge, G. J. Wolbink, C. E. Hack, CRP-MEDIATED ACTIVATION OF COMPLEMENT IN VIVO : ASSESSMENT BY MEASURING CIRCULATING COMPLEMENT-C-REACTIVE PROTEIN COMPLEXES Journal of Immunology. ,vol. 157, pp. 473- 479 ,(1996)
CR Wildevuur, PG Jansen, PD Bezemer, DJ Kuik, L Eijsman, P Bruins, AP De Jong, FW Van Hardevelt, JD Biervliet, JM Hasenkam, HH Kure, L Knudsen, L Bellaiche, P Ahlburg, DY Loisance, C Baufreton, P Le Besnerais, G Bajan, Amine Matta, Michel Van Dyck, M Th Renotte, A Ponlot-Lois, Philippe Baele, EA McGovern, E Ahlvin, None, Clinical evaluation of Duraflo? II heparin treated extracorporeal circulation circuits (2nd version) the European working group on heparin coated extracorporeal circulation circuits European Journal of Cardio-Thoracic Surgery. ,vol. 11, pp. 616- 623 ,(1997) , 10.1016/S1010-7940(96)01122-0
Lhousseine Touqui, Laurence Arbibe, A role for phospholipase A2 in ARDS pathogenesis. Molecular Medicine Today. ,vol. 5, pp. 244- 249 ,(1999) , 10.1016/S1357-4310(99)01470-7
Andrey V. Cybulsky, Tomoko Takano, Joan Papillon, Alison J. McTavish, Complement-induced phospholipase A2 activation in experimental membranous nephropathy1 See Editorial by Shankland, p. 1204. Kidney International. ,vol. 57, pp. 1052- 1062 ,(2000) , 10.1046/J.1523-1755.2000.00932.X
Calvin S.H. Ng, Song Wan, Anthony P.C. Yim, Ahmed A. Arifi, Pulmonary Dysfunction After Cardiac Surgery Chest. ,vol. 121, pp. 1269- 1277 ,(2002) , 10.1378/CHEST.121.4.1269
Lennart Magnusson, Vitas Zemgulis, Stephan Wicky, Hans Tyden, Stefan Thelin, Goran Hedenstierna, Atelectasis is a major cause of hypoxemia and shunt after cardiopulmonary bypass: an experimental study Anesthesiology. ,vol. 87, pp. 1153- 1163 ,(1997) , 10.1097/00000542-199711000-00020